Chimeric Antigen Receptor-T Cell Therapy-Reference-Cited by-同舟云学术

Chimeric Antigen Receptor-T Cell Therapy

Published:2018-01 Issue:1 Volume:2 Page:e18
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Buechner Jochen,Kersten Marie José,Fuchs Miriam,Salmon Florence,Jäger Ulrich

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology

Reference65 articles.

1. Global manufacturing of CAR T cell therapy;Levine;Mol Ther Methods Clin Dev,2016

2. Clinical manufacturing of CAR T cells: foundation of a promising therapy;Wang;Mol Ther Oncolytics,2016

3. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia;Porter;Sci Transl Med,2015

4. Durable remissions after monotherapy with CD19-specific chimeric antigen receptor (CAR)-modified T cells in children and young adults with relapsed/refractory ALL [Abstract S497];Maude;Haematologica,2016

5. Efficacy and safety of CTL019 in the first US phase II multicenter trial in pediatric relapsed/refractory acute lymphoblastic leukemia: results of an interim analysis [Abstract 2801];Maude;Blood,2016

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chimeric Antigen Receptor T-cell based cellular therapies for cancer: An introduction and Indian perspective;Indian Journal of Cancer;2024-04

2. The Art of Bioimmunogenomics (BIGs) 5.0 in CAR-T Cell Therapy for Lymphoma Management;Advanced Pharmaceutical Bulletin;2024-03-10

3. Chimeric Antigen Receptor-T (CAR-T) Cells as “Living Drugs”: A Clinical Pharmacist Perspective;Journal of Clinical Pharmacy and Therapeutics;2024-01-31

4. The Potential of Single‐Chain Variable Fragment Antibody: Role in Future Therapeutic and Diagnostic Biologics;Journal of Immunology Research;2024-01

5. Nursing Care Throughout the Chimeric Antigen Receptor T-Cell Therapy Process for Multiple Myeloma;Seminars in Oncology Nursing;2023-12